Interleukin-1-alpha (Otsuka)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-1-alpha (Otsuka)
Drug Alias NameOCT-8000OCT-7000
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-1 receptor agonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsAnemia, AplasticLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOtsuka Holdings Co Ltd
Active IndicationsN/A
Inactive IndicationsAnemia, AplasticLeukemia

Other Information

ATC CodeN/A
Related LinksN/A